Francois Vigneault, departing Shape Therapeutics CEO
October 17, 2024 01:16 PM EDT
People
Startups
Cell/Gene Tx

RNA gene ther­a­py start­up Shape hunts for new CEO as Se­ries C awaits

Kyle LaHucik

Senior Reporter

Shape Ther­a­peu­tics CEO Fran­cois Vi­gneault has de­part­ed the RNA gene ther­a­py start­up, and chief sci­en­tif­ic of­fi­cer David Huss is fill­ing the post while the Seat­tle …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Post-Hoc: RFK vs. Vivek, and the fu­ture of US drug pol­i­cy

Trump picks vac­cine skep­tic Kennedy to lead HHS, in what would be an up­heaval of US health pol­i­cy

Ei­sai ter­mi­nates Phase 3 tri­al of Dravet drug, cit­ing re­cruit­ment chal­lenges

'Ex­per­tise is a re­al thing': FDA com­mis­sion­er warns of po­lit­i­cal risk to agency

Boston Phar­ma­ceu­ti­cals hits Phase 2 goals as it tries to keep up with MASH com­peti­tors

sponsored

What Will It Take to Re­verse Fi­bro­sis in Pa­tients with Ad­vanced MASH?

A service from the Financial Times